| 2005 Outdoor Soccer League Standings | ||||||||||
| As of: FINAL | ||||||||||
| North Division | Win | Loss | Tie | G/S | Adj. G/S | G/A | Adj. G/A | Pts. | FF | Ratio |
| CDS | 7 | 1 | 0 | 23 | 23 | 7 | 7 | 14 | 1 | 2.286 |
| Picatinny Arsenal | 5 | 2 | 1 | 28 | 28 | 10 | 10 | 11 | 0 | 2.250 |
| Novartis #1 | 4 | 3 | 1 | 19 | 19 | 18 | 18 | 9 | 0 | 0.125 |
| ADP | 4 | 4 | 0 | 9 | 9 | 17 | 17 | 8 | 1 | -1.143 |
| Dicar | 3 | 4 | 1 | 14 | 14 | 14 | 14 | 7 | 0 | 0.000 |
| Deloitte & Touche | 3 | 4 | 1 | 10 | 10 | 18 | 18 | 7 | 1 | -1.143 |
| Tiffany & Co. | 0 | 8 | 0 | 8 | 8 | 28 | 28 | 0 | 1 | -2.857 |
| 26 | 26 | 4 | ||||||||
| South Division | Win | Loss | Tie | G/S | Adj. G/S | G/A | Adj. G/A | Pts. | FF | Ratio |
| Siemens/TDI | 6 | 0 | 1 | 19 | 19 | 7 | 7 | 13 | 1 | 2.000 |
| PricewaterhouseCoopers | 5 | 1 | 1 | 14 | 14 | 9 | 9 | 11 | 2 | 1.000 |
| Solgar | 3 | 4 | 0 | 16 | 16 | 10 | 10 | 6 | 2 | 1.200 |
| DPC | 2 | 4 | 1 | 13 | 13 | 14 | 14 | 5 | 1 | -0.167 |
| Bayer/Honeywell | 2 | 4 | 1 | 6 | 6 | 19 | 19 | 5 | 1 | -2.167 |
| Kraft/PNY | 1 | 6 | 0 | 9 | 9 | 18 | 18 | 2 | 3 | -2.250 |
| 19 | 19 | 4 | ||||||||
| East Division | Win | Loss | Tie | G/S | Adj. G/S | G/A | Adj. G/A | Pts. | FF | Ratio |
| FC-M Life 1863 | 5 | 1 | 1 | 19 | 19 | 4 | 4 | 11 | 2 | 3.000 |
| Bear Stearns | 5 | 2 | 0 | 28 | 27 | 16 | 16 | 10 | 2 | 2.200 |
| Nexius | 4 | 2 | 1 | 30 | 26 | 10 | 10 | 9 | 1 | 2.667 |
| Aircast | 3 | 4 | 0 | 13 | 13 | 20 | 20 | 6 | 1 | -1.167 |
| Novartis # 2 | 2 | 5 | 0 | 8 | 8 | 37 | 23 | 4 | 1 | -2.500 |
| C3i | 1 | 6 | 0 | 9 | 9 | 30 | 29 | 2 | 1 | -3.333 |
| 20 | 20 | 2 | ||||||||
| Mixed Division | Win | Loss | Tie | G/S | Adj. G/S | G/A | Adj. G/A | Pts. | FF | Ratio |
| Ayco/Wyeth | 5 | 0 | 2 | 32 | 30 | 10 | 10 | 12 | 1 | 3.333 |
| Bases | 5 | 1 | 1 | 16 | 16 | 7 | 7 | 11 | 1 | 1.500 |
| HLPP/Quintiles | 3 | 0 | 4 | 11 | 11 | 5 | 5 | 10 | 0 | 0.857 |
| Benjamin Moore/Champion Mortgage | 3 | 3 | 1 | 22 | 22 | 17 | 17 | 7 | 0 | 0.714 |
| Viecore | 2 | 4 | 1 | 10 | 10 | 15 | 15 | 5 | 0 | -0.714 |
| Pfizer | 2 | 4 | 1 | 11 | 11 | 17 | 17 | 5 | 0 | -0.857 |
| Barclays Capital | 2 | 5 | 0 | 11 | 11 | 20 | 20 | 4 | 0 | -1.286 |
| Cendant | 1 | 6 | 0 | 12 | 12 | 34 | 32 | 2 | 0 | -2.857 |
| 23 | 23 | 10 | ||||||||